Induction of apoptosis in MDA-MB-231 human breast carcinoma cells with an ethanol extract of Cyperus rotundus L. by activating caspases

Oncology Reports

Volumn 32, Issue 6, 2014, Pages 2461-2470

  Park, Sang Eun ^a   Shin, Won Tak ^a   Park, Cheol ^a   Hong, Su Hyun ^a   Kim, Gi Young ^b   Kim, Sung Ok ^c   Ryu, Chung Ho ^d   Hong, Sang Hoon ^a   Choi, Yung Hyun ^a  

^a Dong Eui University   (South Korea)

^b Jeju National University   (South Korea)

^c Daegu Haany University   (South Korea)

^d Gyeongsang National University   (South Korea)

Author keywords

Apoptosis; Caspases; Cyperus rotundus L.; MDA MB 231 cells

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CASPASE 8; CASPASE 9; CYPERUS ROTUNDUS EXTRACT; DEATH RECEPTOR 4; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN BAX; SURVIVIN; ALCOHOL; ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; CASPASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARP1 PROTEIN, HUMAN; PLANT EXTRACT; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SOLVENT;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CARCINOMA CELL; CELL COUNT; CELL GROWTH; CELL POPULATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; DNA FRAGMENTATION; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG RESPONSE; GROWTH INHIBITION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; BREAST TUMOR; CELL SURVIVAL; CHEMISTRY; CYPERUS; DRUG EFFECTS; DRUG SCREENING; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; GENETICS; METABOLISM; MITOCHONDRION; RHIZOME; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BREAST NEOPLASMS; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYPERUS; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME ACTIVATION; ETHANOL; FEMALE; GENE EXPRESSION; HUMANS; MITOCHONDRIA; PLANT EXTRACTS; POLY(ADP-RIBOSE) POLYMERASES; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; RHIZOME; SOLVENTS;

EID: 84914688387     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3507     Document Type: Article

References (41)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ and Naghavi M: Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 378: 1461-1484, 2011.
3. Senkus E, Kyriakides S, Penault-Llorca F, Poortmans P, Thompson A, Zackrisson S, Cardoso F; ESMO Guidelines Working Group: Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24 (Suppl 6): vi7-vi23, 2013.
4. Spector D, Deroo LA and Sandler DP: Lifestyle behaviors in black and white women with a family history of breast cancer. Prev Med 52: 394-397, 2011.
5. Danial NN and Korsmeyer SJ: Cell death: critical control points. Cell 116: 205-219, 2004
6. Jin Z and El-Deiry WS: Overview of cell death signaling pathways. Cancer Biol Ther 4: 139-163, 2005.
7. Caroppi P, Sinibaldi F, Fiorucci L and Santucci R: Apoptosis and human diseases: mitochondrion damage and lethal role of released cytochrome c as proapoptotic protein. Curr Med Chem 16: 4058-4065, 2009
8. Kaufmann T, Strasser A and Jost PJ: Fas death receptor signalling: roles of Bid and XIAP. Cell Death Differ 19: 42-50, 2012.
9. Zha J, Weiler S, Oh KJ, Wei MC and Korsmeyer SJ: Post-translational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis. Science 290: 1761-1765, 2000.
10. Chung KM and Yu SW: Interplay between autophagy and programmed cell death in mammalian neural stem cells. BMB Rep 46: 383-390, 2013.
11. Mansilla S, Llovera L and Portugal J: Chemotherapeutic targeting of cell death pathways. Anticancer Agents Med Chem 12: 226-238, 2012.
12. Rufini A and Melino G: Cell death pathology: the war against cancer. Biochem Biophys Res Commun 414: 445-450, 2011.
13. Thebtaranonth C, Thebtaranonth Y, Wanauppathamkul S and Yuthavong Y: Antimalarial sesquiterpenes from tubers of Cyperus rotundus: structure of 10,12-peroxycalamenene, a sesquiterpene endoperoxide. Phytochemistry 40: 125-128, 1995
14. Zhu M, Luk HH, Fung HS and Luk CT: Cytoprotective effects of Cyperus rotundus against ethanol induced gastric ulceration in rats. Phytother Res 11: 392-394, 1997.
15. Uddin SJ, Mondal K, Shilpi JA and Rahman MT: Antidiarrhoeal activity of Cyperus rotundus. Fitoterapia 77: 134-136, 2006.
16. Sharma R and Gupta R: Cyperus rotundus extract inhibits acetylcholinesterase activity from animal and plants as well as inhibits germination and seedling growth in wheat and tomato. Life Sci 80: 2389-2392, 2007
17. Kilani-Jaziri S, Neffati A, Limem I, Boubaker J, Skandrani I, Sghair MB, Bouhlel I, Bhouri W, Mariotte AM, Ghedira K, Dijoux Franca MG and Chekir-Ghedira L: Relationship correlation of antioxidant and antiproliferative capacity of Cyperus rotundus products towards K562 erythroleukemia cells. Chem Biol Interact 181: 85-94, 2009
18. Yazdanparast R and Ardestani A: In vitro antioxidant and free radical scavenging activity of Cyperus rotundus. J Med Food 10: 667-674, 2007
19. Ardestani A and Yazdanparast R: Cyperus rotundus suppresses AGE formation and protein oxidation in a model of fructose-mediated protein glycoxidation. Int J Biol Macromol 41: 572-578, 2007
20. Gupta MB, Palit TK, Singh N and Bhargava KP: Pharmacological studies to isolate the active constituents from Cyperus rotundus possessing anti-inflammatory, anti-pyretic and analgesic activities. Indian J Med Res 59: 76-82, 1971.
21. Seo WG, Pae HO, Oh GS, Chai KY, Kwon TO, Yun YG, Kim NY and Chung HT: Inhibitory effects of methanol extract of Cyperus rotundus rhizomes on nitric oxide and superoxide productions by murine macrophage cell line, RAW 264.7 cells. J Ethnopharmacol 76: 59-64, 2001.
22. Kilani S, Ben Ammar R, Bouhlel I, Abdelwahed A, Hayder N, Mahmoud A, Ghedira K and Chekir-Ghedira L: Investigation of extracts from (Tunisian) Cyperus rotundus as antimutagens and radical scavengers. Environ Toxicol Pharmacol 20: 478-484, 2005.
23. Tsoyi K, Jang HJ, Lee YS, Kim YM, Kim HJ, Seo HG, Lee JH, Kwak JH, Lee DU and Chang KC: (+)-Nootkatone and (+)-valencene from rhizomes of Cyperus rotundus increase survival rates in septic mice due to heme oxygenase-1 induction. J Ethnopharmacol 137: 1311-1317, 2011.
24. Lemaure B, Touché A, Zbinden I, Moulin J, Courtois D, Macé K and Darimont C: Administration of Cyperus rotundus tubers extract prevents weight gain in obese Zucker rats. Phytother Res 21: 724-730, 2007.
25. 2-induced human neuronal cell damage via its anti-oxidative and anti-apoptotic machinery. Cell Mol Neurobiol 33: 5-17, 2013.
26. Hemanth Kumar K, Tamatam A, Pal A and Khanum F: Neuro-protective effects of Cyperus rotundus on SIN-1 induced nitric oxide generation and protein nitration: ameliorative effect against apoptosis mediated neuronal cell damage. Neurotoxicology 34: 150-159, 2013.
27. Fu XC, Shan HL, Bai HB and Hu R: Protective effect of Jiangbaiweiyan tablet on ethanol-induced gastric mucosa injury in rats. Zhejiang Da Xue Xue Bao Yi Xue Ban 40: 391-394, 2011 (In Chinese).
28. He CL, Yi PF, Fan QJ, Shen HQ, Jiang XL, Qin QQ, Song Z, Zhang C, Wu SC, Wei XB, Li YL and Fu BD: Xiang-Qi-Tang and its active components exhibit anti-inflammatory and anticoagulant properties by inhibiting MAPK and NF-κB signaling pathways in LPS-treated rat cardiac microvascular endothelial cells. Immunopharmacol Immunotoxicol 35: 215-224, 2013.
29. Lee SJ, Hwang SO, Noh EJ, Kim DU, Nam M, Kim JH, Nam JH and Hoe KL: Transactivation of bad by vorinostat-induced acetylated p53 enhances doxorubicin-induced cytotoxicity in cervical cancer cells. Exp Mol Med 46: e76, 2014.
30. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG and Earnshaw WC: Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371: 346-347, 1994.
31. Matés JM, Segura JA, Alonso FJ and Márquez J: Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis. Arch Toxicol 82: 273-299, 2008.
32. Trueba GP, Sánchez GM and Giuliani A: Oxygen free radical and antioxidant defense mechanism in cancer. Front Biosci 9: 2029-2044, 2004.
33. Ashkenazi A and Dixit VM: Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 11: 255-260, 1999.
34. Peter ME and Krammer PH: The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 10: 26-35, 2003.
35. Deveraux QL and Reed JC: IAP family proteins - suppressors of apoptosis. Genes Dev 13: 239-252, 1999.
36. Roy N, Deveraux QL, Takahashi R, Salvesen GS and Reed JC: The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 16: 6914-6925, 1997.
37. Schumacker PT: Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 10: 175-176, 2006.
38. Yoeli-Lerner M and Toker A: Akt/PKB signaling in cancer: a function in cell motility and invasion. Cell Cycle 5: 603-605, 2006.
39. Hu L, Hofmann J, Lu Y, Mills GB and Jaffe RB: Inhibition of phosphatidylinositol 3'-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models. Cancer Res 62: 1087-1092, 2002.
40. Kim EK and Choi EJ: Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta 1802: 396-405, 2010.
41. Wagner EF and Nebreda AR: Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9: 537-549, 2009.